pharmacie et médicaments – Décision CEPS d'imposer une baisse massive des prix des médicaments génériques

This procedure concerns a decision by the CEPS (Economic Committee for Health Products) in France to significantly lower the prices of generic medicines. This aims to make treatments more affordable and accessible. Patients, healthcare providers, and pharmaceutical companies producing generic drugs will be directly affected by these price changes. The decision impacts the cost of healthcare for the French population.